Forum on Neuroscience and Nervous System Disorders 2013 Annual Report (2014) / Chapter Skim
Currently Skimming:
Forum on Neuroscience and Nervous System Disorders: 2013 Annual Report
Forum on Neuroscience and Nervous System Disorders: 2013 Annual Report
Pages 1-16
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 1... ...
BOARD ON HEALTH SCIENCES POLICY Forum on Neuroscience and Nervous System Disorders 2013 Annual Report
|
From page 2... ...
Based on such discussions, the Forum sponsors workshops (symposia) , workshop summaries, and commissioned papers as an additional mechanism for informing its membership, other stakeholders, and the public about emerging issues and matters deserving scrutiny.
|
From page 3... ...
In 2013, discussions included diverse topics such as challenges associated with providing evidence-based psychosocial treatments to patients in need; opportunities based on emerging neuroscience technologies to speed potential treatments into first-inhuman trials; mechanisms to standardize data analysis in diffusion magnetic resonance imaging (dMRI) to enhance its potential for research and clinical use; and opportunities created by the federal BRAIN Initiative.
|
From page 4... ...
Moreover, for drugs that are eventually marketed, development, from the start of a discovery program to regulatory approval, can take an average of 12 to 15 years. Among the obstacles to successful drug discovery and devel opment are the limitations of current animal models.
|
From page 5... ...
tools offers great promise, its utility has been held back by a lack of shared standards and clinical validation. Multiple platforms with little, or no, ability to compare results makes it challenging to incorporate dMRI into basic studies of disease and clinical trials.
|
From page 6... ...
The Forum will host an activity to address challenges and examine potential opportunities that would facilitate better management and greater sharing of large basic research datasets. Improving Access to Essential Medicines for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa Sub-Saharan Africa (SSA)
|
From page 7... ...
The Forum will host a series of activities to examine opportunities and risks and discuss appropriate regulatory regimes and the concerns of both developers and payers. Aug 4–5 Nov 9 Feb 25 Jun 17 Sub-Saharan Africa Animal Law 8th meeting 9th meeting Workshop Workshop 2009 Jun 16 Nov 3 Suicidality Workshop 10th meeting
|
From page 8... ...
However, the importance and rapid prolifera tion of mission-critical technologies raises important questions about how to train the next generation of neuroscientists, not only to use particular tools, but to be prepared for a changing technological landscape. In addition, the advent of new types of data and the growing important of large datasets raise additional questions about how to train the next Jun 17 Jun 22 Jul 12 9th meeting Glutamate Workshop ADNI-2 Workshop 2010 2011 2010 Mar 8–9 Jun 23 Dec 10 2011 Sex Differences Workshop 11th meeting 12th meeting
|
From page 9... ...
Current and new components of training programs will be discussed in order to identify methods for enhancing data han dling and analysis capabilities, increasing scientific rigor, and improving research practices. Finally, the roles of mentors, mentees, training program administrators and funders in the development and execution of revised training programs for new and current researchers will be explored.
|
From page 10... ...
The aim of such communication is to inform researchers about how they can contribute to partnerships in a meaningful way, with the goal of improving the neuroscience translational therapeutic development pipeline. Mar 28 Jul 11 Sep 4–5 Nov 28 Mar 5 16th meeting 17th meeting SSA Workshop 18th meeting 19th meeting 2013 Mar 28–29 May 10–11 Oct 4–5 Animal Models Workshop Neurodegeneration Workshop Sharing Clinical Research Data Workshop
|
From page 11... ...
This analysis would include the cost to society and how much it would cost payers if a therapeutic drug were delayed from transitioning to a generic. Apr 8–9 Aug 22 Jan 13-14 Accelerating Therapeutic Meeting on Developing SSA Essential Development Workshop dMRI Standards Medicines Workshop 2014 Dec 2 Feb 18 20th meeting 21st meeting
|
From page 12... ...
2013 Publications Improving the Utility and Neurodegeneration: Translation of Animal Exploring Commonalities Models for Nervous Across Diseases – System Disorders – Workshop Summary Workshop Summary June 17 Oct 28 22nd meeting 23rd meeting 2012 Nov 15 Meeting on Dry AMD
|
From page 13... ...
Sharing Clinical Strengthening Human Resources Through Research Data – Development of Candidate Core Competencies Workshop Summary for Mental, Neurological, and Substance Use Disorders in Sub-Saharan Africa – Workshop Summary
|
From page 14... ...
Thomas Insel Joanne Tornow Broad Institute of the Massachusetts National Institute of Mental Health National Science Foundation Institute of Technology and Harvard Phillip Iredale Nora Volkow Susan Amara Pfizer, Global Research and National Institute on Drug Abuse Society for Neuroscience Development Kenneth Warren Mark Bear Daniel Javitt National Institute on Alcohol Abuse Massachusetts Institute of Columbia University and Alcoholism Technology Frances Jensen David Wholley Katja Brose University of Pennsylvania Health Foundation for the National Institutes Cell Press System of Health Daniel Burch Story Landis John Williams Pharmaceutical Product National Institute of Neurological Wellcome Trust Development, Inc. Disorders and Stroke Stevin Zorn Maria Carrillo Alan Leshner Lundbeck USA Alzheimer's Association American Association for the Charles Zorumski Advancement of Science C
|
From page 15... ...
Alzheimer's Association Department of Veterans Affairs Nonprofit Foundation for the National Institutes of Health GlaxoSmithKline 11% Johnson & Johnson Pharmaceuticals Lilly Research Laboratories Lundbeck USA Federal Merck Research Laboratories 53% The Michael J Fox Foundation for Parkinson's Research 36% National Eye Institute Industry National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse National Institute of Mental Health National Institute of Neurological Disorders and Stroke National Institutes of Health Blueprint for Neuroscience Research National Multiple Sclerosis Society National Science Foundation One Mind for Research Pharmaceutical Product Development, Inc.
|
From page 16... ...
The Institute of Medicine serves as adviser to the nation to improve health. Established in 1970 under the charter of the National Academy of Sciences, the Institute of Medicine provides independent, objective, evidence-based advice to policymakers, health professionals, the private sector, and the public.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.